CompletedNot Applicable

Oocyte Cryopreservation

United States250 participantsStarted 2009-06

Plain-language summary

The specific aim of this study is to further develop methods of oocyte cryopreservation and evaluate their impact on reproductive outcomes.

Age range42 Years

SexFEMALE

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

✓. at risk for ovarian hyperstimulation syndrome (enlarged ovaries with abdominal fluid accumulation) and postponement of pregnancy has been recommended.
✓. a cancer patient anticipating treatment and have been cleared by the oncologists for ovarian stimulation.
✓. a female who seeks to preserve her future fertility and does not wish to use donor or partner sperm to fertilize her eggs.
✓. a donor egg recipient who elects to have some of the eggs obtained fertilized with husband/partner sperm and the rest cryopreserved for future use.
✓. a patient for whom the partner's sperm retrieval or production has failed and donor sperm is not an option.
✓. a patient who, for religious or ethical reasons, wants to limit the number of fresh oocytes exposed to sperm (fertilization) and do not want to either discard or donate the excess oocytes.
✓. has been clinically and psychologically approved for ovarian stimulation
✓. age between 12 and 42 years, inclusive, at time of informed consent.

Survival rate of cryopreserved oocytes with each cryopreservation method

Timeframe: 1 year

Pregnancy rate following thawing/warming of oocytes

Timeframe: 1 year

Implantation rate per embryo transferred

Timeframe: 1 year

NCT IDNCT01696786

SponsorWeill Medical College of Cornell University

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2013-10